1. Coleman RE, Seaman JJ. The role of zoledronic acid in cancer: clinical studies in the treatment and prevention of bone metastases. Semin Oncol. 2001; 28:2 Suppl 6. 11–16.
2. Bobyn JD, Hacking SA, Krygier JJ, Harvey EJ, Little DG, Tanzer M. Zoledronic acid causes enhancement of bone growth into porous implants. J Bone Joint Surg Br. 2005; 87(3):416–420.
3. Wernecke G, Namdari S, DiCarlo EF, Schneider R, Lane J. Case report of spontaneous, nonspinal fractures in a multiple myeloma patient on long-term pamidronate and zoledronic acid. HSS J. 2008; 4(2):123–127.
4. Lenart BA, Neviaser AS, Lyman S, et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. 2009; 20(8):1353–1362.
5. McElfresh EC, Coventry MB. Femoral and pelvic fractures after total hip arthroplasty. J Bone Joint Surg Am. 1974; 56(3):483–492.
6. Sharkey PF, Hozack WJ, Callaghan JJ, et al. Acetabular fracture associated with cementless acetabular component insertion: a report of 13 cases. J Arthroplasty. 1999; 14(4):426–431.
7. Sanchez-Sotelo J, McGrory BJ, Berry DJ. Acute periprosthetic fracture of the acetabulum associated with osteolytic pelvic lesions: a report of 3 cases. J Arthroplasty. 2000; 15(1):126–130.
8. Gelalis ID, Politis AN, Arnaoutoglou CM, Georgakopoulos N, Mitsiou D, Xenakis TA. Traumatic periprosthetic acetabular fracture treated by acute one-stage revision arthroplasty: a case report and review of the literature. Injury. 2010; 41(4):421–424.
9. Andrews P, Barrack RL, Harris WH. Stress fracture of the medial wall of the acetabulum adjacent to a cementless acetabular component. J Arthroplasty. 2002; 17(1):117–120.
10. Cermak K, Shumelinsky F, Alexiou J, Gebhart MJ. Case reports: subtrochanteric femoral stress fractures after prolonged alendronate therapy. Clin Orthop Relat Res. 2010; 468(7):1991–1996.